Q&A: Novo Nordisk research chief discusses streamlined R&D, asset integration and role of AI

Novo Nordisk's global research head Jacob Sten Petersen discusses post-reorganization R&D strategy, pipeline diversification beyond semaglutide, and AI's role in drug discovery.

Raccontata daendpoints.news